Uterine Cancer Clinical Trials in Oklahoma City, Oklahoma
2 recruitingOklahoma City, Oklahoma
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab884 enrolled66 locationsNCT05579366
Recruiting
Phase 1
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Endometrial CancerUterine Cancer
Washington University School of Medicine36 enrolled4 locationsNCT06795009